Literature DB >> 19133977

Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly.

Ilaria Del Giudice1, Stefano A Pileri, Maura Rossi, Elena Sabattini, Cristina Campidelli, Irene Della Starza, Maria S De Propris, Francesca Mancini, Maria P Perrone, Paola Gesuiti, Daniele Armiento, Luisa Quattrocchi, Agostino Tafuri, Angela Amendola, Francesca R Mauro, Anna Guarini, Robin Foà.   

Abstract

Five cases of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly are reported; three were splenectomized. BCL2/IGH rearrangements were found in three cases; HLA-DRB1*07 in all. Bone marrow (BM) trephines showed a moderate lymphoid infiltrate with intrasinusoidal distribution resembling a splenic marginal-zone lymphoma. Splenic white pulp revealed an enlargement of the marginal-zone area; red pulp was infiltrated by the same lymphocytes engulfing the sinuses. Splenic and BM B-lymphocytes were CD79a(+)/CD20(+)/IgM(+)/IgD(+)/bcl-2(+)/CD27(+)/DBA.44(-)/CD31(-) and polyclonal by immunophenotype/polymerase chain reaction. PPBL features an expansion of splenic marginal-zone B-lymphocytes, which infiltrate BM sinusoids and circulate in the blood with no evidence of clonality, even in cases with progressive splenomegaly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19133977     DOI: 10.1111/j.1365-2141.2008.07551.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Progressive gammopathy and coagulopathy in a young English bulldog.

Authors:  Jennifer L Grady; Anne Avery; A Russell Moore; Lauren J Harris; Neketa Kakar; Emily D Rout
Journal:  Can Vet J       Date:  2021-02       Impact factor: 1.008

2.  Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.

Authors:  Falko Fend; José Cabecadas; Philippe Gaulard; Elaine S Jaffe; Philip Kluin; Isinsu Kuzu; Loann Peterson; Andrew Wotherspoon; Christer Sundström
Journal:  J Hematop       Date:  2012-09       Impact factor: 0.196

3.  B-cell signaling in persistent polyclonal B lymphocytosis (PPBL).

Authors:  Nadine Voelxen; Claudia Wehr; Sylvia Gutenberger; Baerbel Keller; Miriam Erlacher; Cecilia Dominguez-Conde; Daniela Bertele; Florian Emmerich; Milena Pantic; Stefanie Jennings; Mirzokhid Rakhmanov; Christian Foerster; Uwe M Martens; Uwe Platzbecker; Hans-Hartmut Peter; Paul Fisch; Kaan Boztug; Hermann Eibel; Ulrich Salzer; Klaus Warnatz
Journal:  Immunol Cell Biol       Date:  2016-04-29       Impact factor: 5.126

4.  Recent advances in bone marrow biopsy pathology.

Authors:  Jon van der Walt
Journal:  J Hematop       Date:  2009-05-14       Impact factor: 0.196

5.  Persistent Polyclonal B Cell Lymphocytosis B Cells Can Be Activated through CD40-CD154 Interaction.

Authors:  Emmanuelle Dugas-Bourdages; Sonia Néron; Annie Roy; André Darveau; Robert Delage
Journal:  Adv Hematol       Date:  2014-12-14

6.  Symptomatic Massive Splenomegaly in Persistent Polyclonal B-cell Lymphocytosis Requiring Splenectomy.

Authors:  Shanel B Bhagwandin; Elliot S Weisenberg; Howard Ozer; Ajay V Maker
Journal:  Open J Clin Med Case Rep       Date:  2015-06-29

7.  Persistent Polyclonal B-Cell Lymphocytosis with Binucleated Lymphocytes

Authors:  Berrin Balık Aydın; Yaşa Gül Mutlu; Ömür Gökmen Sevindik
Journal:  Turk J Haematol       Date:  2021-03-10       Impact factor: 1.831

Review 8.  Histological and immunohistochemical features of the spleen in persistent polyclonal B-cell lymphocytosis closely mimic splenic B-cell lymphoma.

Authors:  Ping Sun; Ridas Juskevicius
Journal:  Diagn Pathol       Date:  2012-08-19       Impact factor: 2.644

9.  Polyclonal B-cell lymphocytosis in English bulldogs.

Authors:  Emily D Rout; A Russell Moore; Robert C Burnett; Julia D Labadie; Kelly L Hughes; Paul A Navin; Janna A Yoshimoto; Paul R Avery; Anne C Avery
Journal:  J Vet Intern Med       Date:  2020-10-15       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.